Variant report
Variant | nsv968023 |
---|---|
Chromosome Location | chr4:173098597-173113255 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:173103489..173104997-chr4:173109245..173111025,2 | MCF-7 | breast: | |
2 | chr4:173111162..173113888-chr4:173117599..173120346,2 | MCF-7 | breast: | |
3 | chr4:173050637..173053046-chr4:173107907..173109625,2 | MCF-7 | breast: | |
4 | chr4:173103489..173104997-chr4:173109245..173111025,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185946576 | chr4:173109004-173109005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138963170 | chr4:173109033-173109034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72700992 | chr4:173109066-173109067 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs113999039 | chr4:173109078-173109079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551465292 | chr4:173109089-173109090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143811648 | chr4:173109110-173109111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528986670 | chr4:173109194-173109195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549072300 | chr4:173109230-173109231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs72700993 | chr4:173109276-173109277 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs531370028 | chr4:173109295-173109296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551375640 | chr4:173109298-173109299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28431282 | chr4:173109317-173109318 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs77877506 | chr4:173109337-173109338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547582232 | chr4:173109338-173109339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567304999 | chr4:173109344-173109345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs189838759 | chr4:173109348-173109349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544750731 | chr4:173109439-173109440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556271028 | chr4:173109442-173109443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147251227 | chr4:173109469-173109470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564565071 | chr4:173109476-173109477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138770147 | chr4:173109502-173109503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558517478 | chr4:173109530-173109531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183157236 | chr4:173109531-173109532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116438267 | chr4:173109532-173109533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115099512 | chr4:173109593-173109594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540600283 | chr4:173109597-173109598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs2202281 | chr4:173109636-173109637 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs544008624 | chr4:173109639-173109640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs836315 | chr4:173109642-173109643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531423192 | chr4:173109674-173109675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7669963 | chr4:173109800-173109801 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs564677830 | chr4:173109802-173109803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527590858 | chr4:173109862-173109863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547349076 | chr4:173109869-173109870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs75426518 | chr4:173109879-173109880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144761066 | chr4:173109889-173109890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549557116 | chr4:173109896-173109897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs372884144 | chr4:173109917-173109918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569863101 | chr4:173109932-173109933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs6553616 | chr4:173109961-173109962 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs148559443 | chr4:173109993-173109994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565900871 | chr4:173110015-173110016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187933205 | chr4:173110026-173110027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs114201456 | chr4:173110058-173110059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs115159166 | chr4:173110128-173110129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs369725334 | chr4:173110161-173110162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544068823 | chr4:173110173-173110174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557583388 | chr4:173110216-173110217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190455584 | chr4:173110268-173110269 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575696607 | chr4:173110271-173110272 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 22127048 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 22341455 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:173109000-173110200 | Enhancers | HepG2 | liver |
2 | chr4:173109600-173110000 | Enhancers | Gastric | stomach |
3 | chr4:173109800-173110200 | Enhancers | Brain Germinal Matrix | brain |
4 | chr4:173110000-173110400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr4:173110200-173110400 | Weak transcription | Brain Germinal Matrix | brain |
6 | chr4:173110400-173110800 | Enhancers | Brain Germinal Matrix | brain |
7 | chr4:173110600-173111600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr4:173110800-173111800 | Weak transcription | Brain Germinal Matrix | brain |
9 | chr4:173111800-173112000 | Enhancers | Brain Germinal Matrix | brain |